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Sarcoidosis presenting as granulomatous
myositis in a 16-year-old adolescent
Amir B. Orandi1, Eric Eutsler2, Cole Ferguson3, Andrew J. White1 and Maleewan Kitcharoensakkul1*
Abstract
Background: Sarcoidosis is a multi-system disease characterized by the presence of non-caseating epithelioid
granulomas in affected tissues, including skeletal muscle. These organized collections of immune cells have
important pathophysiologic action including cytokine production leading to inflammation as well as enzymatic
conversion of cholecalciferol to calcitriol via 1-α hydroxylase. There are limited reports of isolated granulomatous
myositis causing hypercalcemia in pediatric patients. Our patient uniquely presented with symptoms from
hypercalcemia and renal insufficiency caused by an overwhelming burden of granulomatous myositis in her lower
extremities, but was otherwise asymptomatic.
Case presentation: A 16 year old Caucasian female presented with protracted symptoms of fatigue, nausea and
prominent weight loss with laboratory evidence of hypercalcemia and renal insufficiency. She lacked clinical and
physical findings of arthritis, weakness, rash, uveitis, fever, lymphadenopathy or respiratory symptoms. After
extensive negative investigations, re-examination yielded subtle soft tissue changes in her lower extremities,
with striking MRI findings of extensive myositis without correlative weakness or serum enzyme elevation.
Biopsy showed the presence of non-caseating epithelioid granulomas and calcium oxalate crystals. The patient
responded well to prednisone and methotrexate but relapsed with weaning of steroids. She reachieved
remission with addition of adalimumab.
Conclusions: Sarcoidosis should be considered in patients presenting with symptomatic hypercalcemia with
no apparent causes and negative routine workup. The absences of decreased muscle strength or elevated
muscle enzymes do not preclude the diagnosis of granulomatous myositis.
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Background
Sarcoidosis is a multi-system autoimmune disease
characterized by the presence of non-caseating epithe-
lioid granulomas in various organs and tissues. In
young children, there is a distinct form of the disease
best known as Blau syndrome which presents with a
characteristic triad of granulomatous dermatitis, uve-
itis and polyarticular synovitis and tenosynovitis [1].
Older children with sarcoidosis typically display clin-
ical disease features similar to adults with predomin-
antly pulmonary disease and lymphadenopathy with
frequent constitutional symptoms [2]. Despite these
clinical phenotypes, there is significant variation in
the clinical symptoms of the disease and diagnosis
has long relied on histopathology. We herein report
on an unusual presentation of sarcoidosis in a 16-
year-old adolescent.
Case presentation
A 16-year-old previously healthy Caucasian female pre-
sented with fatigue, nausea and weight loss of 10 kg over
a three month period. She had no fever, night sweats,
myalgia, arthralgia, rash or pulmonary symptoms. There
was no history of sick contacts or recent travel. Apart
from visible fatigue and clinically apparent weight loss,
her physical examination revealed normal cardiopulmo-
nary exams, and no hepatosplenomegaly, arthritis or
skin findings. Initial laboratory studies revealed a white
blood count of 7.2 K/cumm, hemoglobin of 12.1 g/dl,
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hematocrit of 36.4 %, platelets of 315 K/cumm with nor-
mal absolute numbers of neutrophils and lymphocytes.
Chemistries were notable for total serum calcium of
13.1 mg/dl (reference 8.6-10.3 mg/dl), ionized calcium of
6.16 mg/dl (reference 3.9-5.2 mg/dl), and creatinine of
1.2 mg/dl. Her phosphorus and magnesium were within
normal limits. The urine calcium to creatinine ratio was
elevated with a ratio of 0.85. These results were followed
with additional testing showing an intact parathyroid
hormone of 5 pg/mL (reference 14–72 pg/ml), elevated
1–25 Vitamin D level of 168 ng/ml (reference 24–86 pg/
ml) and an elevated angiotensin converting enzyme
(ACE) level of 268 Units/L (reference 10–55 Units/L).
These findings raised concern for granulomatous dis-
ease. A broad infectious evaluation for tuberculosis (by
PPD and Quantiferon), histoplasmosis, blastomyces,
syphilis, and trichinella were negative. Stool calprotec-
tin was negative. A chest radiograph was negative for
lymphadenopathy or parenchymal changes. A con-
trasted CT scan of the chest, abdomen and pelvis also
showed no lymphadenopathy or hepatosplenomegaly.
A bone marrow biopsy showed hypocellular marrow
with erythroid hyperplasia, but absence of malignancy
or granulomas. Other serologies showed antinuclear
antibody (ANA) positive titer of 1:320 in speckled pat-
tern and negative anti-neutrophil cytoplasmic anti-
bodies (ANCA). She was given intravenous hydration
up to 3 L/m2 of body surface area to maintain a normal
calcium level.
During her evaluation, the patient continued to be
symptomatic from hypercalcemia with fatigue, nausea
and vomiting and had progressive normocytic anemia
to a nadir of hemoglobin 9.1 g/dl with elevated
erythrocyte sedimentation rate (ESR) of 31 mm/h (ref-
erence < 20 mm/h). A repeat physical examination re-
vealed soft tissue enlargement with a firm consistency
bilaterally in the lower extremities distal to the knees
(Fig. 1a). There were no overlying skin changes or ten-
derness to palpation. Strength and deep tendon reflexes
of the extremities were preserved. Plain radiographs
and ultrasound showed soft tissue enlargement and
muscular hypertrophy respectively without focal changes
or calcifications. Laboratory testing for myositis showed
creatine kinase of 23 Units/L (reference < 300 Units/L),
aldolase 5.7 Units/L (reference < 14.7 Units/L), lactate de-
hydrogenase (LDH) of 177 Units/L (reference 100–200
Units/L) and normal serum transaminases. Magnetic res-
onance imaging (MRI) of the bilateral lower extremities
revealed extensive myositis involving every muscle in both
legs (Figs. 1b and 2). There was a mass-like area in the
lateral head of the left gastrocnemius muscle (Fig. 3a).
Needle electromyography (EMG) showed fibrillations and
positive sharp waves in the right medial gastrocnemius
and myopathic polyphasic potentials with mild early re-
cruitment compatible with myopathy. Nerve conduction
studies were normal. A biopsy was obtained with gross tis-
sue intraoperatively described as pale and edematous. Mi-
croscopy showed a destructive macrophage-rich process
with well-formed non-necrotizing granulomas, numer-
ous giant cells and sparse residual muscle. Some giant
cells contained polarizable crystalline material most
compatible with calcium oxalate (Fig. 3b and c). Special
studies were employed to exclude Langerhans cell
histiocytosis and infection with fungal or acid fast
Fig. 1 a Photograph of lower extremity hypertrophy. b Comparison to coronal T2 MRI showing symmetric hypertrophy of lower extremity musculature
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Fig. 2 a Axial short tau inversion recovery (STIR) image of both legs demonstrates extensive myositis bilaterally with extensive edema involving
all of the calf muscles within the anterior, posterior and lateral compartments. b Diffusion-weighted sequence reveals patchy areas of restricted
diffusion throughout multiple muscles in both legs (arrows), also consistent with acute inflammation. Also note associated intermuscular
fascial edema
Fig. 3 a Coronal contrast-enhanced T1 image with fat saturation shows an ill-defined, mass-like area in the lateral head of the left gastrocnemius
muscle with central intermediate signal, central non-enhancement, and peripheral hyper-enhancement. Biopsy was taken from area of area. b Skeletal
muscle involved by severe granulomatous inflammation with osteoclast-like giant cells. c Polarization showing crystalline material compatible with
calcium oxalate
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organisms. A slip lamp and dilated eye exam did not
demonstrate uveitis. Spirometry including lung volume
and diffuse lung capacity were normal. Echocardiogram
showed no abnormalities. Based on her clinical symptoms,
pathology findings, and the exclusion of other causes, the
diagnosis of sarcoidosis was made. She was initiated on a
prednisone taper and weekly subcutaneous methotrexate
at 15 mg/m2, with improvement in her symptoms of fa-
tigue and nausea and normalization of her calcium and
ACE levels. However, due to difficulty weaning off ste-
roids, adalimumab 40 mg every 2 weeks was added three
months after diagnosis with sustained improvement.
Conclusion
Pediatric sarcoidosis is rare with an estimated incidence
of 0.2 per 100, 000 per year. The mean age of onset is
13–15 years, but presentations may vary with age [1, 2].
The hallmark finding of sarcoidosis are the presence of
non-caseating epithelioid granulomas, which are believed
to be an antigen-driven cell-mediated immune response
involving CD4+ T cells that eventually differentiate into
Type 1 T helper (Th1) cells which then secrete IL-2
and IFN-γ, supporting macrophage TNF-α production,
promoting the cellular immune response [3, 4]. The re-
cruited and organized immune cell collections include
activated macrophages that have been shown to pro-
duce 1-α hydroxylase which converts cholecalciferol
(25-OH Vitamin D) to calcitriol (1, 25-dihydroxy Vita-
min D) [5]. Calcitriol then increases intestinal calcium
absorption and bone resorption leading to hypercalce-
mia and/or hypercalciuria, known to be frequent fea-
tures of the disease particularly in those with high
granuloma burden. Epithelioid cells of the granulomata
produce angiotensin converting enzyme (ACE), a contro-
versial biomarker of sarcoidosis that is often elevated, but
lacks diagnostic specificity and sensitivity [6, 7]. Thus,
some laboratory findings could be suggestive of granu-
loma presence and activity, but pursuit must be taken
to find tissue for histopathologic confirmation and
diagnosis. In a recent review of 101 adult cases of
calcitriol-mediated hypercalcemia, approximately half
were eventually diagnosed with sarcoidosis [8]. Overall,
granulomata are an infrequent finding on skeletal
muscle biopsies [9]. When isolated, sarcoidosis and
idiopathic granulomatous myositis are the two most
frequent causes, respectively. Symptomatic presenta-
tions of sarcoid myopathy have multiple phenotypes
including nodular and atrophic forms and are more
often from chronic disease [10]. The frequency of
asymptomatic granulomatous myositis in sarcoidosis
has been estimated between 50 and 80 % and occurs
more often in early stages of the disease [11]. Our case
underscores the importance of considering sarcoidosis
or granulomatous myositis in patients who present with
hypercalcemia of unclear etiology and reinforces the
need for tissue diagnosis and exclusion of other causes.
MRI showed excellent utility in detecting granuloma-
tous myositis in patients without typical myositis fea-
tures and anti-TNF monoclonal antibody therapy was
efficacious in our refractory case.
Abbreviations
ACE: Angiotensin-converting enzyme; ANA: Antinuclear antibody; ANCA: Anti-
neutrophil cytoplasmic antibodies; EMG: Electromyography; ESR: Erythrocyte





No funding was used for the creation of this manuscript.
Availability of data and materials
Not applicable.
Authors’ contributions
All authors participated in the clinical management of the patient. AO
drafted the manuscript with critical revisions provided by AW and MK.
EU provided radiologic interpretation and CF provided histopathologic
interpretation. All authors reviewed and approved the final draft of the
manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Written informed consent for publication of their clinical details and/or
clinical images was obtained from the parent of the patient. A copy of
the consent form is available for review by the Editor of this journal.
Ethics approval and consent to participate
Not applicable. IRB exemption on file if needed.
Author details
1Department of Pediatrics, Division of Rheumatology, Washington University
School of Medicine, One Children’s Place, Campus Box 8116, St. Louis, MO,
USA. 2Department of Radiology, Division of Pediatric Radiology, Washington
University School of Medicine, St. Louis, MO, USA. 3Department of Pathology
and Immunology, Washington University School of Medicine, St. Louis, MO,
USA.
Received: 11 August 2016 Accepted: 3 November 2016
References
1. Miceli-Richard C, Rybojad M, Prieur AM, et al. CARD15 mutations in Blau
syndrome. Nat Genet. 2001;29:19–20.
2. Wouters C, Maes A, Foley K, et al. Blau Syndrome, the prototypic auto-
inflammatory granulomatous disease. Pediatr Rheumatol Online J. 2014;
12:33.
3. Barnard J, Newman L. Sarcoidosis: Immunology, rheumatic involvement,
and therapeutics. Curr Opin Rheumatol. 2001;13:84–91.
4. Iannuzzi M, Rybicki B, Teirstein A. Sarcoidosis. N Engl J Med. 2007;357:2153–65.
5. Shetty A, Gedalia A. Childhood sarcoidosis: A rare but fascinating disorder.
Pediatr Rheumatol Online J. 2008;6:16.
6. Adams JS, Ma G. Characterization of 1 alpha-hydroxylation of vitamin D3
sterols by cultured alveolar macrophages from patients with sarcoidosis.
J Exp Med. 1985;161:755–65.
7. Keir G, Wells A. Assessing Pulmonary Disease and Response to Therapy:
Which Test? Semin Respir Crit Care Med. 2010;31(4):409–18.
8. Donovan PJ, Sundac L, Pretorious MC, et al. Calcitriol-Mediated Hypercalcemia:
Causes and Course in 101 patients. J Clin Endocrinol Metab. 2013;98:4023–9.
Orandi et al. Pediatric Rheumatology  (2016) 14:59 Page 4 of 5
9. Prayson R. Granulomatous myositis, clinicopathologic study of 12 cases.
Am J Clin Pathol. 1999;112:63–8.
10. Prieto-Gonzalez S, Grau JM. Diagnosis and classification of granulomatous
myositis. Autoimmun rev. 2014;13:372–4.
11. Silverstein A, Stiltzbach L. Muscle involvement in sarcoidosis. Arch Neurol.
1969;21:235–41.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Orandi et al. Pediatric Rheumatology  (2016) 14:59 Page 5 of 5
